Abstract
The rare case is reported of advanced hepatocellular carcinoma (HCC) in a 50-year-old male with type 1 neurofibromatosis (NF 1). The patient presented in the surgical outpatient department with a 4-year history of multiple neurofibromas over the trunk and complaints of pain in the right upper abdomen for 4 months, progressive weight loss and loss of appetite. Investigation for both the abdominal complaints and the multiple neurofibromas led to the diagnosis of advanced HCC (according to the Barcelona Clinic Liver Cancer Sstaging and Treatment Strategy) with NF 1, and the patient is being managed on oral Sorafenib as palliative treatment. NF 1 occurs due to mutation in the NF 1 gene located on 17q, which codes for the protein neurofibromin, which has a tumor suppressor function. NF1 presents rarely with malignancy, in which case tumors of the central nervous system are the most common type. To the best of our knowledge this is only the second documented case of NF 1 presenting with HCC.
Similar content being viewed by others
References
Korf B. Malignancy in neurofibromatosis type 1. The Oncologist 2000;5:477–85.
Lewis RA, Gerson LP, Axelson KA, et al. von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata. Ophthalmology 1984;91:929–35.
Martin GA, Viskochil D, Bollag G, et al. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 1990;63:843–9.
Ishioka C, Ballester R, Engelstein M, et al. A functional assay for heterozygous mutations in the GTPase activating protein related domain of the neurofibromatosis type 1 gene. Oncogene 1995;10:841–7.
Calvisi DF, Ladu S, Conner EA, et al. Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer. J Hepatol 2011;54:311–9.
Walker L, Thompson D, Easton D, et al. A prospective study of neurofibromatosis type 1 cancer incidence in the UK. Br J Cancer 2006;95:233–8.
Sorensen SA, Mulvihill JJ, Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis: Survival and malignant neoplasms. N Engl J Med 1986;314:1010–5.
Huson SM, Harper PS, Compston DAS. Von Recklinghausen neurofibromatosis: A clinical and population study in South-East Wales. Brain 1988;111:1355–81.
Friedman JM, Birch PH. Type 1 neurofibromatosis: A descriptive analysis of the disorder in 1728 patients. Am J Med Genet 1997;70:138–43.
Kimura T, Tanaka N, Umemura T, et al. Primary hepatocellular carcinoma in a patient with neurofibromatosis type I. Liver International 2015:210–15.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chaudhary, P., Munjewar, C. & Kumar, R. Advanced Hepatocellular Carcinoma in a Patient with Type 1 Neurofibromatosis. Hellenic J Surg 90, 151–153 (2018). https://doi.org/10.1007/s13126-018-0461-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13126-018-0461-3